Article info
Congenital heart disease
Original research
Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure
- Correspondence to Dr Anastasia D Egorova, Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands; a.egorova{at}lumc.nl
Citation
Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure
Publication history
- Received December 30, 2022
- Accepted April 12, 2023
- First published May 11, 2023.
Online issue publication
September 28, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.